Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

Talaris Therapeutics, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/06/2021 3 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Agarwala Sandip (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Srivastava Sapna (Director) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Clarus Defined Exit I, L.P. (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 MCDADE MARK (Director) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 GALAKATOS NICHOLAS (Director) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Longitude Capital Partners III, LLC (10% Owner) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Requadt Scott (See Remarks) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 MACKAY GEOFFREY (Director) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Krieger Nancy (Chief Medical Officer) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Shah Gaurav (Director) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Zdanowski Michael (Chief Technology Officer) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Nader Francois (Director) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Ildstad Suzanne (Chief Scientific Officer) has filed a Form 3 on Talaris Therapeutics, Inc.
05/06/2021 3 Fenton Mary Kay (CFO) has filed a Form 3 on Talaris Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy